Analysis: Vaccine joy sparks share price snakes and ladders
Welcome news of a coronavirus vaccine has sparked a stock market shift as investors rushed to buy and sell shares. Big-name retail and other consumer stocks shunned during the pandemic were back in fashion, while lockdown stars took a hit.
Global stock markets soared after it was revealed on Monday that pharmaceutical developers Pfizer and BioNTech had successfully completed trials of a coronavirus vaccine in six countries, proving it to be 90% effective.
With the prospect of restrictions easing over the coming months, some of the darling stocks of the pandemic saw their luck turn, while other struggling companies returned to favour.
Already have an account? Sign in here